{"id":282,"date":"2021-06-01T00:17:37","date_gmt":"2021-06-01T00:17:37","guid":{"rendered":"https:\/\/www.pharmascience.com\/?page_id=282"},"modified":"2026-01-05T08:42:48","modified_gmt":"2026-01-05T13:42:48","slug":"pharmaceutical-rd","status":"publish","type":"page","link":"https:\/\/pharmascience-02.beauvoir.dev\/en\/pharmaceutical-rd\/","title":{"rendered":"R&D"},"content":{"rendered":"\n\n
\n
\n
\n
\n <\/div>\n <\/div>\n
\n
\n \n
\n

R&D<\/p>\n

Improving Generic Medicines Everyday <\/h1>\n <\/div>\n <\/div>\n \n \n \n <\/div>\n <\/div>\n<\/section>\n\n\n\n\n
\n
\n
\n
\n
\n

Leader in Research & Development<\/h2>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n
\n

Year-in, year-out, we are amongst Canada\u2019s Top 100 R&D investors, all domains confounded, according to the trusted, independent, Research Info Source survey, proving that a leading generic manufacturer can also be a major R&D contributor since 2015.<\/p>\n\n <\/div>\n\n

\n\n
\n \n <\/div>\n\n \n\n \n <\/section>\n\n <\/div>\n <\/div>\n<\/section>\n\n\n\n\n
\n
\n
\n\n
\n
\n \"\"\n <\/div>\n <\/div>\n
\n
\n\n
\n

\n \n \n\n<\/svg>\n\n <\/span>\n We are steadily investing in R&D in the areas of formulation of new generics, bioequivalence testing, and clinical research. All Pharmascience R&D is conducted in Canada and contributes significantly to pharmaceutical innovation.\n \n \n\n<\/svg>\n\n \n <\/span>\n <\/p>\n <\/blockquote>\n
\n Alain Carrier<\/cite>\n
Vice President, Scientific Affairs<\/span>\n <\/figcaption>\n<\/figure>\n\n <\/div>\n <\/div>\n <\/div>\n<\/section>\n\n\n\n\n

\n
\n
\n
\n
\n

A Top 100 R&D Investor<\/h2>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n
\n

Over the past 20 years,Research Info Source Inc. has consistently ranked Pharmascience on the list of Canada\u2019s Top 100 Corporate R&D Investors, with R&D spending oscillating between ~65 million $ per year. We, as a private, Canadian-owned company, have made it a strategic choice to invest all of our R&D in Canada.<\/p>\n\n <\/div>\n\n

\n\n
\n \n <\/div>\n\n \n\n \n <\/section>\n\n <\/div>\n <\/div>\n<\/section>\n\n\n\n\n
\n
\n
\n
\n
\n \"\"\n <\/div>\n <\/div>\n
\n

Best-in-Class Scientific Expertise<\/h3>\n
\n

We have a dedicated team of 115+ science experts with educational credentials ranging from PhD, MSc, BSc to technical diplomas. With backgrounds in organic and analytical chemistry, biology, medical sciences, biopharmaceutics, pharmacy, and engineering, our scientists are all devoted to the development of new generic pharmaceutical products for Canadian and global markets. Operating in formulation, technology transfer and project management teams, each member uses their specialized skills to achieve that goal.<\/p>\n\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n<\/section>\n\n\n\n\n

\n
\n
\n
\n
\n \"\"\n <\/div>\n <\/div>\n
\n

Sharing our Expertise<\/h3>\n
\n

The Pharmascience R&D team is also in demand throughout our industry by third parties who contract our expertise for the development of generic and innovative drug products.<\/p>\n

Our integrated product development model includes:<\/p>\n